ESR1 and breast carcinoma: Significant differences were also observed in the β2-M protein expression levels between the ER+ and ER− breast cancer groups (P < 0.01); 58.09% (ER+) and 81.39% (ER-) positive staining were observed in the breast cancer specimen sections.